Interleukin-23 and Th17 Cells in the Control of Gut Inflammation
Crohn's Disease and Ulcerative Colitis, the major forms of inflammatory bowel diseases (IBDs) in humans, have been traditionally associated with exaggerated and poorly controlled T helper (Th) type 1 or Th2 cell response, respectively. More recent studies have, however, shown that IBDs are als...
Saved in:
Main Authors: | Ivan Monteleone, Francesco Pallone, Giovanni Monteleone |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2009/297645 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Overview of the Role of Innate Lymphoid Cells in Gut Infections and Inflammation
by: Silvia Sedda, et al.
Published: (2014-01-01) -
The role of interleukin-17 in inflammation-related cancers
by: Xingru Zhang, et al.
Published: (2025-01-01) -
Diagnostic value of interleukins 23 and 17 in the assessment of ulcerative colitis severity
by: M.V. Stoikevych, et al.
Published: (2024-12-01) -
Effects of interleukin-12/23 inhibitors and interleukin-17 inhibitors on myocardial functions in patients with severe psoriasis
by: Leyla Baykal Selçuk, et al.
Published: (2024-12-01) -
Balancing Inflammation: The Link between Th17 and Regulatory T Cells
by: Maggie L. Diller, et al.
Published: (2016-01-01)